Literature DB >> 6151681

Protective antigens of rodent and human bloodstage malaria.

A A Holder, R R Freeman.   

Abstract

Bloodstage malaria parasites are antigenically complex, but individual antigens can be identified and analysed using monoclonal antibodies. Two monoclonal antibodies that recognize a 235 000 molecular mass Plasmodium yoelii rhoptry protein provide some protection when injected into mice against a challenge infection. The purified rhoptry protein also provides protective immunity against P. yoelii YM when used to vaccinate mice and fulminating infections are converted into self-limiting, reticulocyte-restricted infections. Another monoclonal antibody immunoprecipitates a 230 000 molecular mass protein and a series of proteolytic processing fragments. At least one of these processing fragments, probably a 90 000 molecular mass species, is located on the merozoite surface. Mice immunized with the purified protein were protected against challenge infection with P. yoelii YM. This antigen may provide protection by inducing a cell-mediated immune response. A monoclonal antibody raised against P. falciparum schizonts reacts with a 195 000 molecular mass protein which is synthesized in schizonts and subsequently cleaved. Fragments of the 195 000 molecular mass protein are expressed as major antigens on the merozoite surface. The 195 000 molecular mass P. falciparum protein and the 230 000 molecular mass P. yoelii protein belong to a class of malaria parasite antigens which probably is important in the induction of a protective immune response in the host.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151681     DOI: 10.1098/rstb.1984.0117

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  14 in total

1.  Sensitive and specific DNA probe for detection of Plasmodium falciparum.

Authors:  V Enea
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

2.  In vivo selection of populations of Plasmodium chabaudi chabaudi AS resistant to a monoclonal antibody that reacts with the precursor to the major merozoite surface antigen.

Authors:  J C Wood; J C Sales de Aguiar; W Jarra; S A Ogun; G Snounou; K N Brown
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

3.  Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.

Authors:  Angela Trieu; Matthew A Kayala; Chad Burk; Douglas M Molina; Daniel A Freilich; Thomas L Richie; Pierre Baldi; Philip L Felgner; Denise L Doolan
Journal:  Mol Cell Proteomics       Date:  2011-05-31       Impact factor: 5.911

4.  Genomic heterogeneity in the density of noncoding single-nucleotide and microsatellite polymorphisms in Plasmodium falciparum.

Authors:  Sarah K Volkman; Elena Lozovsky; Alyssa E Barry; Trevor Bedford; Lara Bethke; Alissa Myrick; Karen P Day; Daniel L Hartl; Dyann F Wirth; Stanley A Sawyer
Journal:  Gene       Date:  2006-08-14       Impact factor: 3.688

5.  Transdermal immunization of P. falciparum surface antigen (MSP-119) via elastic liposomes confers robust immunogenicity.

Authors:  Rajeev K Tyagi; Neeraj K Garg; Sarat K Dalai; Amit Awasthi
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

6.  The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.

Authors:  Christian A Darko; Evelina Angov; William E Collins; Elke S Bergmann-Leitner; Autumn S Girouard; Stacy L Hitt; Jana S McBride; Carter L Diggs; Anthony A Holder; Carole A Long; John W Barnwell; Jeffrey A Lyon
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

7.  Antibody recognition of rodent malaria parasite antigens exposed at the infected erythrocyte surface: specificity of immunity generated in hyperimmune mice.

Authors:  M M Mota; K N Brown; V E Do Rosário; A A Holder; W Jarra
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.

Authors:  Qifang Shi; Michelle M Lynch; Margarita Romero; James M Burns
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

9.  Changes in parasite virulence induced by the disruption of a single member of the 235 kDa rhoptry protein multigene family of Plasmodium yoelii.

Authors:  Devaki Bapat; Ximei Huang; Karthigayan Gunalan; Peter R Preiser
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

Review 10.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.